Frontage Laboratories Executive and Leadership Team

June, 2026

Leadership Overview

Frontage Laboratories has 5 executives leading key functions including strategy, operations, and finance.

Driven by scientific rigor, Frontage Laboratories is dedicated to accelerating drug development through integrated, science-driven product development services, enabling pharmaceutical and biotechnology companies to achieve their development goals and advance critical molecules through regulatory submissions globally.

Leadership Roles at Frontage Laboratories

  • Co-Chief Executive Officer - Jonathan Lin
  • Co-Chief Executive Officer - Daniella Kranjac
  • Co-Chief Executive Officer - Zhongping Lin
  • Interim Chief Financial Officer - Huan Wang
  • Chief Operating Officer - Min Wang
  • Jonathan Lin - Co-Chief Executive Officer

    Jonathan Lin, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching strategy and operational execution for the company's comprehensive drug discovery and development services. Lin guides the integration of science-driven solutions across the entire product development lifecycle, ensuring Frontage Laboratories effectively supports pharmaceutical and biotechnology clients in achieving their development objectives. This leadership involves fostering innovation in areas such as drug metabolism and pharmacokinetics, analytical testing, and formulation development. Jonathan Lin also oversees the expansion of services, including preclinical safety and toxicology assessment and early phase clinical studies, to meet evolving industry demands. The focus remains on enabling clients to advance molecules through development and secure regulatory submissions in key global markets. Lin's strategic direction ensures Frontage Laboratories maintains its position as a leading CRO, facilitating the progression of numerous molecules through critical development stages.

    Daniella Kranjac - Co-Chief Executive Officer

    Daniella Kranjac, the Co-Chief Executive Officer at Frontage Laboratories, spearheads the strategic vision and global expansion initiatives for the contract research organization. Kranjac drives the company's mission to provide integrated, science-driven product development services, enabling pharmaceutical and biotechnology partners to achieve their critical development goals. This involves overseeing the comprehensive suite of services, from drug discovery through to regulatory submissions, including bioanalysis, preclinical safety, and early phase clinical studies. Daniella Kranjac ensures that Frontage Laboratories remains at the forefront of scientific innovation, adapting to the complex needs of advancing molecules through development. The leadership focuses on enhancing client success by optimizing processes in areas like drug metabolism and pharmacokinetics and formulation development. Kranjac's strategic oversight is crucial for maintaining Frontage Laboratories' competitive edge and facilitating the successful progression of client projects across the United States, China, and other international markets.

    Zhongping Lin - Co-Chief Executive Officer

    Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, drives the strategic direction and operational excellence across the company's diverse service offerings. Lin is instrumental in ensuring the seamless integration of science-driven solutions that support pharmaceutical and biotechnology clients throughout their product development journey. This encompasses a broad spectrum of services, including drug metabolism and pharmacokinetics, analytical testing, formulation development, and manufacturing of preclinical and clinical trial materials. Zhongping Lin's leadership ensures that Frontage Laboratories consistently delivers high-quality bioanalysis, preclinical safety, and toxicology assessments. The focus is on enabling clients to efficiently advance molecules through development and achieve successful regulatory submissions in the United States, China, and other global regions. Lin's strategic vision reinforces Frontage Laboratories' commitment to accelerating drug development and achieving client objectives.

    Huan Wang - Interim Chief Financial Officer

    Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, oversees the financial strategy and fiscal management of the contract research organization. Wang ensures robust financial planning and analysis to support the company's integrated, science-driven product development services. This leadership role involves managing financial operations that enable pharmaceutical and biotechnology companies to achieve their development goals, from drug discovery through to regulatory submissions. Huan Wang's responsibilities include overseeing the financial aspects of bioanalysis, preclinical safety, toxicology assessment, and early phase clinical studies. The focus is on maintaining financial stability and optimizing resource allocation across all service areas, including drug metabolism and pharmacokinetics, analytical testing, and formulation development. Wang's financial stewardship is critical for Frontage Laboratories' continued growth and success in advancing client molecules through development.

    Min Wang - Chief Operating Officer

    Min Wang, the Chief Operating Officer at Frontage Laboratories, directs the day-to-day operational execution of the company's integrated drug development services. Wang ensures the efficient delivery of comprehensive solutions, including drug metabolism and pharmacokinetics, analytical testing, and formulation development, supporting pharmaceutical and biotechnology clients in achieving their development goals. This operational leadership encompasses the management of bioanalysis, preclinical safety, and toxicology assessment services, ensuring scientific rigor and regulatory compliance. Min Wang oversees the manufacturing of preclinical and clinical trial materials, critical for advancing molecules through development. The focus is on optimizing internal processes to enhance client success and facilitate regulatory submissions in the United States, China, and other key markets. Wang's role is vital in maintaining the high standards of service delivery that Frontage Laboratories provides.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Frontage Laboratories Top Executives and Leadership Team

    Who leads Frontage Laboratories?
    Frontage Laboratories is led by Jonathan Lin (Co-Chief Executive Officer), along with executives such as Daniella Kranjac (Co-Chief Executive Officer) and Zhongping Lin (Co-Chief Executive Officer).
    Who is part of Frontage Laboratories’s executive team?
    The executive team of Frontage Laboratories includes leaders such as Jonathan Lin (Co-Chief Executive Officer), Daniella Kranjac (Co-Chief Executive Officer), Zhongping Lin (Co-Chief Executive Officer) and other senior executives.
    How many executives does Frontage Laboratories have?
    Frontage Laboratories has 5 executives leading key business areas.
    What roles are included in Frontage Laboratories’s leadership team?
    The leadership team of Frontage Laboratories includes roles such as Co-Chief Executive Officer, Co-Chief Executive Officer, Co-Chief Executive Officer, Interim Chief Financial Officer, Chief Operating Officer.